Form 4: MKS Director Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


MKS Inc. Director Elizabeth Mora sold 300 shares of common stock for $239.44 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

  • Elizabeth Mora, a Director of MKS Inc. (MKSI), reported a sale of common stock.
  • The transaction involved the disposition of 300 shares of MKS Inc. common stock.
  • The shares were sold at a price of $239.44 per share.
  • The sale occurred on March 2, 2026.
  • Following this transaction, Elizabeth Mora directly beneficially owns 18,663.394 shares of common stock.
  • The transaction was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on February 19, 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it is an insider sale, the execution under a pre-arranged 10b5-1 plan mitigates any negative signaling, as it is not a discretionary sale based on new information.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 trading plans are common practice for corporate insiders. These plans allow individuals to pre-arrange sales of company stock to avoid accusations of trading on material non-public information. Such transactions are generally viewed as less indicative of management's sentiment about the company's future prospects compared to discretionary, unplanned sales.

Stakeholder Impact

  • Shareholders: The sale of 300 shares by a director is a minor transaction and is unlikely to have a significant impact on shareholder sentiment or the company's stock price, especially given it was pre-planned.

Key Dates

DateDescription
02/19/2025Date Rule 10b5-1 trading plan was adopted by Elizabeth Mora.
03/02/2026Date of common stock transaction (sale).
03/03/2026Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

The reported transaction is a routine insider sale executed under a Rule 10b5-1 trading plan. This type of pre-scheduled sale typically does not reflect new information about the company's performance or outlook and is not significant enough in size to warrant a change in investment recommendation. Investors should continue to evaluate MKS Inc. based on its fundamental financial performance and broader market conditions.

Keywords

MKS, MKSI, Insider Trading, Form 4, Stock Sale, Director, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.